AL161431.1 is identified as a biomarker for bladder cancer progression and immunotherapy response

AL161431.1 is identified as a biomarker for bladder cancer progression and immunotherapy response

Abstract LncRNA AL161431.1 is currently known as a factor that can promote epithelial-mesenchymal transition. However, its role in the prognosis, immune infiltration and progression of bladder cancer (BLCA)patients is still unclear. The expression of AL161431.1 is elevated in BLCA tissues compared t...

Full description

Saved in:
Bibliographic Details
Main Authors: Sihao Zhang, Yaxuan Wang, Zhenwei Han, Baosai Lu, Kexin Sun, Zhihai Teng, Chenggen Jin, Fang Li, Hao Yuan, Fengran Guo, Yanping Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
LncRNA AL161431.1
Bladder cancer
Tumor immune microenvironment
Diagnosis
Tumor mutation burden (TMB)
Epithelial-mesenchymal transition (EMT)
Online Access:https://doi.org/10.1038/s41598-024-82425-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-82425-4

Similar Items